Latest Amphetamines Stories
WASHINGTON, June 20, 2011 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement in response to Texas Governor Rick Perry signing into law legislation that implements a real-time, stop-sale system allowing law-abiding citizens to access common cold and allergy medicines containing pseudoephedrine (PSE), while stopping sales that exceed the legal limit: "We applaud the work of Texas lawmakers who enacted legislation implementing a real-time,...
GREENWOOD VILLAGE, Colo., June 8, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.
Long-term relationships make the commonly abused drug amphetamine less appealing, according to a new animal study in the June 1 issue of The Journal of Neuroscience.
DUBLIN, May 25, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its subsidiary Shire LLC has received Paragraph IV Notice Letters from Amneal Pharmaceuticals, LLC.
Top selling Sinupret® and Bronchipret® now available only through Bioforce USA Ghent, NY (PRWEB) May 22, 2011 Bioforce USA is pleased to announce that it has acquired the distribution rights for Bionorica products in the US, effective immediately.
DUBLIN, May 19, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its subsidiary Shire LLC has received a Paragraph IV Notice Letter from Sandoz Inc.
Stop Sale Technology Will Allow Consumers Access To Cold & Allergy Medicines, While Blocking Criminals WASHINGTON, May 13, 2011 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) today released the following statement in response to Indiana Governor Mitch Daniels signing into law a bill that requires the state to track all purchases of products containing pseudoephedrine (PSE) in real time allowing retailers and pharmacists to block sales to any individual who...
Scientists are reporting development of three promising formulations that could be used in a vaccine to treat methamphetamine addiction â€” one of the most serious drug abuse problems in the U.S.
WASHINGTON, May 9, 2011 /PRNewswire-USNewswire/ -- The following is a statement by Scott M.
PHILADELPHIA, April 28, 2011 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced positive results from a signal-finding study of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII) assessing its effect in a prospective examination of adults with negative symptom predominant schizophrenia.
- A hairdresser.